Al Altomari, Chairman and CEO
Agile Therapeutics
Margaret Anderson, Managing Director
Deloitte
Charlene Banard, Head of Quality, Technical Operations
Shire
Jeffrey Berkowitz, Board Member
H. Lundbeck A/S
Liz Bywater, Ph.D., President
Bywater Consulting Group
Ron Cohen, M.D., President & CEO
Acorda Therapeutics
Laurie Cooke, CEO
Healthcare Businesswomen's Association (HBA)
John Crowley, Chairman and CEO
Amicus Therapeutics
Rich Daly, Chief Operating Officer
Beyond Spring
Raúl Díaz, Animal Health Large Molecules Biopharm. Operations
MSD, Montes Claros, MG, Brazil
Tom Dilenge, President, Advocacy, Law & Public Policy Division
Biotechnology Innovation Organization
Joseph Ferra, CFO
Syros Pharmaceuticals
Tim Garnett, M.D., CMO & SVP of Medicines Development
Eli Lilly
Anu Hans, VP, Strategic Initiatives
Janssen Supply Chain
Fred Hassan, Managing Director
Warburg Pincus
Paul Hastings, President and CEO
Nkarta Therapeutics
Axel Hoos, M.D., Ph.D., SVP Oncology R&D
GSK
John Hubbard, Ph.D., Emeritus Editorial Advisory Board Member
Life Science Leader
Maik Jornitz, CEO
G-CON Manufacturing
Mitchell Katz, Ph.D., Vice President, Development Operations
Ferring Pharmaceutical, Inc.
Mary Rose Keller, VP, Clinical Operations
Heron Therapeutics
Rachel King, CEO
GlycoMimetics
Suresh Kumar, Former EVP External Affairs
Sanofi
John LaMattina, Ph.D., Sr. Partner
PureTech Health
Martin Lehr, CEO
Context Therapeutics
Craig Lipset, Head of Clinical Innovation, Global Product Development
Pfizer
Sandy Macrae, Ph.D., President & CEO
Sangamo Therapeutics
Ken Moch, President & CEO
Cognition Therapeutics
Bernard Munos, Founder
InnoThink Center for Research in Biomedical Innovation
Carol Nacy, Ph.D., CEO
Sequella
Francois Nader, M.D., Chairman of the Board
Acceleron Pharma
Julia Owens, Ph.D., President and CEO
Millendo Therapeutics
Mark Petrich, Ph.D., PE, Director, Single-Use Systems Engineering
Merck
Sandra Poole, Chief Operating Officer
LogicBio Therapeutics Inc.
Dennis Purcell, Founder & Sr. Advisor
Aisling Capital
David Pyott, Chairman of the Board
Bioniz Therapeutics
Chandra Ramanathan, Ph.D., MBA, VP & Head, East Coast Innovation Center
Bayer
Stephen Rapundalo, Ph.D., President & CEO
MichBio
John Reynders, Ph.D., VP, R&D strategy, program management, and data sciences
Alexion
James Robinson, Emeritus Editorial Advisory Board Member
Life Science Leader
Tomasz Sablinski,M.D., Ph.D., Cofounder & CEO
Transparency Life Sciences
Chhaya Shah, SVP Technical Operations
Radius Health
Allan Shaw, Board of Directors
Vivus Inc.
Andrew Skibo, Emeritus Editorial Advisory Board Member, Life Science Leader
MedImmune / AstraZeneca
Jason Urban, Ph.D., Head of External Engagement
Bristol-Myers Squibb
Thomas Wiggans, Founder, CEO, Chairman
Dermira
Leslie Williams, Founder, President & CEO
ImmusanT

IN THIS MONTH'S ISSUE

More From Current Issue

@LIFESCILEADER1

 EVENTS

Developing a Part 11 Compliance Plan in Clinical Research March 26 - 26, 2019
1:00 PM - 2:30 PM EDT
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!
Competency-Based Training in a GMP Environment – Results Based on Roles and Responsibilities March 27 - 27, 2019
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
INTERPHEX April 2 - 4, 2019
New York, NY
Implementing a Robust Change Control Program – Key Elements for Process and Documentation Compliance April 4 - 4, 2019
1pm-2:30pm EDT, Online Training
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!
Authoring and Implementing Standard Operating Procedures (SOPs): Best Practices for Success April 9 - 9, 2019
1pm-2:30pm EST, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!